1. 866 Preclinical Study of Pamiparib, a CNS Penetrant PARP Inhibitor, in IDH1/2 Mutated Gliomas. (April 2023) Authors: Hong, Christopher Sungwoon; Sundaram, Ranjini; Bindra, Ranjit Journal: Neurosurgery Issue: Volume 69(2023)Supplement 1 Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bi‐allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer. Issue 2 (27th April 2017) Authors: Mutter, Robert W; Riaz, Nadeem; Ng, Charlotte KY; Delsite, Rob; Piscuoglio, Salvatore; Edelweiss, Marcia; Martelotto, Luciano G; Sakr, Rita A; King, Tari A; Giri, Dilip D; Drobnjak, Maria; Brogi, Edi; Bindra, Ranjit; Bernheim, Giana; Lim, Raymond S; Blecua, Pedro; Desrichard, Alexis; Higginson, D... Journal: Journal of pathology Issue: Volume 242:Issue 2(2017) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CBIO-14. ELUCIDATING THE MECHANISM OF TEMOZOLOMIDE-INDUCED ATR ACTIVATION IN MGMT-METHYLATED GLIOBLASTOMA MULTIFORME. (9th November 2020) Authors: Ganesa, Sachita; Sule, Amrita; Sundaram, Ranjini; Bindra, Ranjit Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CBIO-28. IDENTIFYING THE ROLE OF MISMATCH REPAIR IN TEMOZOLOMIDE-INDUCED ATR ACTIVATION FOR MGMT-METHYLATED GLIOBLASTOMA MULTIFORME. (12th November 2021) Authors: Ganesa, Sachita; Sule, Amrita; Sundaram, Ranjini; Bindra, Ranjit Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical Efficacy of Olaparib in IDH1/IDH2-Mutant Mesenchymal Sarcomas. (2021) Authors: Eder, Joseph P.; Doroshow, Deborah B.; Do, Khanh T.; Keedy, Vicki L.; Sklar, Jeffrey S.; Glazer, Peter; Bindra, Ranjit; Shapiro, Geoffrey I. Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical Efficacy of Olaparib inIDH1/IDH2‐Mutant Mesenchymal Sarcomas. (December 2021) Authors: Eder, Joseph P.; Doroshow, Deborah B.; Do, Khanh T.; Keedy, Vicki L.; Sklar, Jeffrey S.; Glazer, Peter; Bindra, Ranjit; Shapiro, Geoffrey I. Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CLRM-03. BGB-290 AND TEMOZOLOMIDE IN TREATING ISOCITRATE DEHYDROGENASE (IDH)1/2-MUTANT GRADE I-IV GLIOMAS – A NOVEL MODEL OF AYA TRIAL DEVELOPMENT AND DEPLOYMENT. (21st September 2021) Authors: Marks, Asher; Bindra, Ranjit Journal: Neuro-oncology advances Issue: Volume 3(2021)Supplement 4 Page Start: iv1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CTNI-18. PHASE I AND PRELIMINARY PHASE 0 RESULTS OF ABTC 1801: A MULTI-ARM CLINICAL TRIAL OF THE PARP INHIBITOR PAMIPARIB (BGB290) WITH VERY LOW DOSE METRONOMIC TEMOZOLOMIDE IN RECURRENT IDH MUTANT GLIOMAS. (12th November 2021) Authors: Schiff, David; Bindra, Ranjit; Li, Jing; Ye, Xiaobu; Ellingson, Benjamin; Walbert, Tobias; Campian, Jian; Nabors, L Burt; Lieberman, Frank; Ozer, Byran; Desai, Arati; Omuro, Antonio; Wen, Patrick; Desideri, Serena; Fisher, Joy; Grossman, Stuart Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DNA polymerase beta participates in DNA End-joining. Issue 1 (17th November 2017) Authors: Ray, Sreerupa; Breuer, Gregory; DeVeaux, Michelle; Zelterman, Daniel; Bindra, Ranjit; Sweasy, Joann B Journal: Nucleic acids research Issue: Volume 46:Issue 1(2018) Page Start: 242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. EXTH-55. TEMOZOLOMIDE-RESISTANT GLIOMA CELLS ARE SENSITIVE TO CHLOROETHYLATING NITROSOUREA COMPOUNDS IN COMBINATION WITH ATR INHIBITORS. (11th November 2019) Authors: Jackson, Christopher; Kalathil, Aravind; Bindra, Ranjit Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗